Nanobacterie Overview

  • Founded
  • 2008
Founded
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Nanobacterie General Information

Description

Developer of a magnetic nanoparticles based treatment therapy designed to treat cancerous tumors. The company's therapy uses nanoparticles containing iron oxide, which are introduced into solid tumors and then subjected to an alternating magnetic field, enabling doctors to dissolve tumor tissue through this therapy.

Contact Information

Website
www.nanobacterie.fr
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Therapeutic Devices
Primary Office
  • Batiment 201
  • Université Paris-Sud
  • 91405 Orsay
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanobacterie Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Nanobacterie’s complete valuation and funding history, request access »

Nanobacterie Patents

  • 77

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 6

    Pending

  • 000

    Expiring in next 12 mo

Nanobacterie Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3747409-A1 Nanoparticle for use in a method of treating a body part of an individual by non-predominant ice-ball cryotherapy Pending 03-Jun-2019 00000000 0
CA-3136792-A1 Method for increasing the release of medical compounds from nanoparticles by an alteration step and a physico-chemical disturbance step Pending 25-Apr-2019 000000000
FR-3095340-A1 Process for increasing the release of medical compounds from nanoparticles after an alteration stage and a physico-chemical disturbance stage Pending 25-Apr-2019 000000000 0
JP-2020078293-A Production of high-purity iron oxide nanoparticles in cell Pending 02-Oct-2018 00000000
CA-3057346-A1 Cellular production of pure iron oxide nanoparticles Pending 02-Oct-2018 C12P3/00
To view Nanobacterie’s complete patent history, request access »

Nanobacterie Executive Team (1)

Name Title Board Seat Contact Info
Laurence Rivain Co-Founder & Board Member
To view Nanobacterie’s complete executive team members history, request access »

Nanobacterie Board Members (1)

Name Representing Role Since
Laurence Rivain Nanobacterie Co-Founder & Board Member 000 0000
To view Nanobacterie’s complete board members history, request access »

Nanobacterie Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Agoranov Accelerator/Incubator 000 0000 000000 0
To view Nanobacterie’s complete investors history, request access »

Ready to get started?

Request a free trial